Trademark Overview
On Friday, August 22, 2025, a trademark application was filed for PERSEUS SENOLYTIX with the United States Patent and Trademark Office. The USPTO has given the PERSEUS SENOLYTIX trademark a serial number of 99351616. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, January 22, 2026. This trademark is owned by SENOTHERAPEUTIX, Inc.. The PERSEUS SENOLYTIX trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Anti-cancer therapy; Anti-cancer services;Anti-cancer research; Anti-aging therapy; Anti-aging services; Anti-aging research; Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of cancer and age-related diseases; Testing, inspection, research, or development of pharmaceutical preparations for cancer therapy and age therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; Peptides for use in cancer and age-related diseases; Peptides for use in skin conditions; Anti-cancer peptides; Anti-aging peptides; Peptides for use in prevention of radiation damage; Peptides for use in treatment of radiation damage; Peptides for use in prevention of radiation related diseases; Peptides for use in treatment of radiation related diseases; Biologic ag...
Medical research services; Medical research services, namely, anti-cancer and anti-aging services; Medical research services, namely, prevention and treatment of cancer and age-related disorders; Medical advisory services; Medical advisory services, namely, anti-cancer and anti-aging services; Medical advisory services, namely, prevention and treatment of cancer and age-related disorders; Medical testing services; Medical testing services, namely, anti-cancer and anti-aging services; Medical testing services, namely, prevention and treatment of cancer and age-related disorders; Medical services in the field of anti-cancer and anti-aging; Medical services in the field of senescent cells; Medical services in the field of cancer and age-related disorders; Biopsy services; Biopsy services related to cancer; Biopsy services related to biologic age; Biopsy services related to biological age scoring; Biopsy services related to determining a number or percentage of senescent cells; Laboratory ...
